Patient Related Outcomes-BODE (PRO-BODE): A composite index incorporating health utilization resources predicts mortality and economic cost of COPD in real life

Respiratory Medicine - Tập 131 - Trang 175-178 - 2017
R.W. Dal Negro1, B.R. Celli2
1Centro Nazionale Studi di Farmacoeconomia e, Farmacoepidemiologia Respiratoria – CESFAR, Verona, Italy
2Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA

Tài liệu tham khảo

Global Initiative for Chronic Obstructive Lung Disease Mannino, 2015, Economic burden of chronic obstructive pulmonary disease by presence of comorbidities, Chest, 147, 1199, 10.1378/chest.15-0380 Mathers, 2006, Projections of global mortality and burden of disease from 2002 to 2030, PLoS Med., 3, e442, 10.1371/journal.pmed.0030442 Dal Negro, 2015, Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update, Clin. Econ. Outcomes Res., 7, 153, 10.2147/CEOR.S77504 Traver, 1979, Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study, Am. Rev. Respire. Dis., 119, 895 Celli, 2004, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease, N. Engl. J. Med., 350, 1005, 10.1056/NEJMoa021322 Briggs, 2008, Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease, Arch. Intern. Med., 168, 71, 10.1001/archinternmed.2007.37 Halpin, 2008, Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data, Respir. Med., 102, 1615, 10.1016/j.rmed.2008.05.007 Celli, 2008, Predictors of survival in COPD: more than just FEV1, Respir. Med., 102, S27, 10.1016/S0954-6111(08)70005-2 Ko, 2011, A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD, Respir. Med., 105, 266, 10.1016/j.rmed.2010.06.022 Gudmundsson, 2012, Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries, Intern. J. COPD, 7, 571 Boutou, 2013, Lung function indices for predicting mortality in COPD, Eur. Respir. J., 42, 616, 10.1183/09031936.00146012 Motegi, 2013, A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations, Intern. J. COPD, 8, 259, 10.2147/COPD.S42769 Moberg, 2014, Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation, COPD, 11, 381, 10.3109/15412555.2013.836171 Pedone, 2014, BODE index or geriatric multidimensional assessment for the prediction of very-long-term mortality in elderly patients with chronic obstructive pulmonary disease ? A prospective cohort study, Age Ageing, 43, 553, 10.1093/ageing/aft197 Lombolt, 2014, Meta-analysis of routine blood tests as predictors of mortality in COPD, Eur. Clin. Respir.J, 1 Goossens, 2014, Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbation and mortality: a post-hoc analysis of the 4-year UPLIFT trial, BMC Pulm. Med., 10.1186/1471-2466-14-163 Chen, 2015, J. Am. Geriatr. Soc., 63, 244, 10.1111/jgs.13258 Navarro, 2015, Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index, Rev. Clin. Esp., 215, 431, 10.1016/j.rce.2015.06.004 Cote, 2006, Surrogates of mortality in chronic obstructive pulmonary disease, Am. J. Med., 119, 54, 10.1016/j.amjmed.2006.08.008 Celli, 2010, Predictors of mortality in COPD, Respir. Med., 104, 773, 10.1016/j.rmed.2009.12.017 Oga, 2011, Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease, Int. J. Chron. Obstruct. Pulmon. Dis., 6, 521, 10.2147/COPD.S24420 Italian Ministry of Health, 2013 Siafakas, 1995, Optimal assessment of management of chronic obstructive pulmonary disease (COPD), Eur. Respir. J., 8, 1398, 10.1183/09031936.95.08081398 Pauwels, 2001, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global initiative for Chronic Obstructive Lung disease )GOLD) Work-shop summary, Am. J. Respire. Crit. Care Med., 163, 1256, 10.1164/ajrccm.163.5.2101039 Nocturnal Oxygen Therapy Trial Group, 1980, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial, Ann. Intern Med., 93, 391, 10.7326/0003-4819-93-3-391 Gerardi, 1996, Variables related to increased mortality following outpatient pulmonary rehabilitation, Eur. Respir. J., 9, 431, 10.1183/09031936.96.09030431 Nishimura, 2002, Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD, Chest, 121, 1434, 10.1378/chest.121.5.1434 Schols, 1998, Weight loss is reversible factor in the prognosis of chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 157, 1791, 10.1164/ajrccm.157.6.9705017 Landbo, 1999, Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am. Rev. Respir. Crit. Care Med., 160, 1856, 10.1164/ajrccm.160.6.9902115 Hurst, 2010, Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease, N. Engl. J. Med., 363, 1128, 10.1056/NEJMoa0909883